NYSE:MEDMedifast Stock Price, Forecast & News

Medifast's stock was trading at $70.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MED shares have increased by 117.0% and is now trading at $152.85. View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Medifast.

Medifast is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Medifast.

Medifast Inc (NYSE:MED) issued its quarterly earnings results on Tuesday, May, 5th. The specialty retailer reported $1.93 EPS for the quarter, topping analysts' consensus estimates of $1.33 by $0.60. The specialty retailer earned $178.46 million during the quarter, compared to analyst estimates of $161.90 million. Medifast had a return on equity of 65.66% and a net margin of 10.41%. View Medifast's earnings history.

Medifast announced a quarterly dividend on Tuesday, June 16th. Shareholders of record on Tuesday, June 30th will be paid a dividend of $1.13 per share on Thursday, August 6th. This represents a $4.52 annualized dividend and a yield of 2.96%. The ex-dividend date of this dividend is Monday, June 29th. View Medifast's dividend history.

4 analysts have issued 12-month target prices for Medifast's shares. Their forecasts range from $86.00 to $164.00. On average, they expect Medifast's stock price to reach $113.33 in the next year. This suggests that the stock has a possible downside of 25.9%. View analysts' price targets for Medifast.

Media headlines about MED stock have trended neutral recently, InfoTrie reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Medifast earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned media stories about the specialty retailer a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Medifast.

Some companies that are related to Medifast include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Prestige Consumer Healthcare (PBH), USANA Health Sciences (USNA), Inter Parfums (IPAR), Revlon (REV), Veru (VERU) and Nature's Sunshine Products (NATR). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), Home Depot (HD), Boeing (BA), Mastercard (MA), Micron Technology (MU), AbbVie (ABBV), Adobe (ADBE), Paypal (PYPL) and Baidu (BIDU).

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

Medifast's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.05%) and Carroll Financial Associates Inc. (0.01%). Company insiders that own Medifast stock include Carl E Sassano, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, Michael A Hoer, Michael C Macdonald and Scott Schlackman. View institutional ownership trends for Medifast.

MED stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., and Carroll Financial Associates Inc.. Company insiders that have bought Medifast stock in the last two years include Daniel R Chard, Jeffrey J Brown, and Michael A Hoer. View insider buying and selling activity for Medifast.

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MED stock can currently be purchased for approximately $152.85.

Medifast has a market capitalization of $1.80 billion and generates $713.67 million in revenue each year. The specialty retailer earns $77.92 million in net income (profit) each year or $5.96 on an earnings per share basis. Medifast employs 420 workers across the globe.

The official website for Medifast is www.medifast1.com.

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]